SCHEMBL7672434

SCHEMBL7672434

CCOC(=O)c1ccc(NNc2cccc(C(=O)OCC)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ TSHR P16473 1/20 0.60
▸ SMN1; SMN2 Q16637 8/20 0.60
▸ RAB9A P51151 8/20 0.60
▸ NPC1 O15118 6/20 0.60
▸ MAPT P10636 3/20 0.60
▸ MEN1 O00255 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.59
▸ CDC25B P30305 2/20 0.59
▸ MAPK1 P28482 2/20 0.59
▸ LMNA P02545 2/20 0.59
▸ GAA P10253 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ TRPV1 Q8NER1 1/20 0.58
▸ POLB P06746 1/20 0.58
▸ PKM P14618 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28141853 0.88 RAB9A (0.67) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL28849404 0.87 SMN1; SMN2 (0.72) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL19654563 0.86 KMT2A (0.62) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL4124085 0.85 MAPT (0.81) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL584215 0.83 KMT2A (0.65) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL4920497 0.82 MAPT (0.75) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL971445 0.81 KMT2A (0.63) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL3092388 0.81 KMT2A (0.63) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL27334690 0.81 SMN1; SMN2 (0.62) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL28142629 0.81 SMN1; SMN2 (0.59) ALDH1A1KMT2ATSHRSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity SIKORSKI JAMES A (US) 2002-11-07 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, PLTP ALDH1A1 2588/4885KMT2A 3855/4885TSHR 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback